ALK and lung carcinoma: These traits might shed light on the biological mechanisms underlying the relatively aggressive nature of lung cancers with ALK rearrangements and suggest potential therapeutic approaches to overcome ALK inhibitor resistance and stop EMT-mediated metastasis (Kim et al. 2017b; Kwak et al. 2010).